India全球化资本 IGC 深 沪
等待开盘 03-26 09:30:00 美东时间
0.2647
+0.012
+4.62%
华盛通- 最 高0.2734
- 今 开0.26
- 成交量 25.53万股
- 最 低 0.25
- 昨 收 0.253
- 总市值 2515.66万
- 52周最高 0.4985
- 市盈率 静 --
- 换手率 0.27%
- 52周最低 0.242
- 委 比 0.00%
- 总股本 9503.80万
- 历史最高 14.58
- 量 比 0.92
- 振 幅 9.25%
- 历史最低 0.242
- 每 手 1
- 风险率 0.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多'Medicare CBD Pilot Will Allow Some THC in Products'- Cannabis Wire
https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_read=1773920530418
03-19 22:30
IGC Pharma Q3 EPS $(0.01) Beats $(0.02) Estimate, Sales $213.000K Miss $325.000K Estimate
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 50 percent increase over losses of $(0.02) per share from the same period
03-19 21:25
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.75 to $5.
02-23 18:00
'GOP Congressman Isn't Sure Marijuana Rescheduling Is A DOJ 'Priority,' But Remains Optimistic About Progress Under Trump' - Marijuana Moment
https://www.marijuanamoment.net/gop-congressman-isnt-sure-marijuana-rescheduling-is-a-doj-priority-but-remains-optimistic-about-progress-under-trump/
02-11 00:19
IGC Pharma Expands Phase 2 CALMA Trial Into Colombia
- Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst -
02-09 21:38
IGC Pharma Q2 EPS $(0.02), Inline, Sales $191.000K Miss $325.000K Estimate
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $191.000 thousand
2025-11-17 21:38
IGC Pharma Unit Enters Sale Of Assets Agreement For $2.7M
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001326205/000118518525001326/igc8k100125.htm
2025-10-02 04:46
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4.5
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.25 to $4.5.
2025-08-26 18:07
Igc Pharma’s Risky Venture: Navigating Financial Instability Amid Bitcoin Investment Plans
Igc Pharma, Inc. (IGC) has disclosed a new risk, in the Debt & Financing ca...
2025-08-16 14:01
